Thus, attenuating HG‐induced BMSC dysfunction by inhibiting the pathological activation of RAGE signalling could represent a rather promising strategy to prevent impaired bone formation as well as T1DM‐related bone loss. Here, AGER is linked to type 1 diabetes mellitus.